Product Images Levalbuterol Inhalation

This is a graph that shows the mean change in forced expiratory volume (FEV) in percentage for different treatments (lev 0.63, lev 031, rac 2.5, rac 1.25, and placebo) over a period of 4 hours. The number of participants (n) for each treatment is also provided.*

This appears to be a chart showing the mean change in FEV (Forced Expiratory Volume) over time measured in hours for different treatments. The treatments are labeled as Lev 063, Lev0.31, Rac 2.5, Rac 1.25, and Pbo (placebo), with the number of subjects (n) in each treatment group indicated alongside the label. The chart displays five data points ranging from 0 to 4 hours on the x-axis and incremental values of FEV change on the y-axis.*

The text describes an image labeled as Figure A which contains a unit-dose vial with a twist-off tab portion shaded in a different color.*

The text contains only a list of words and a reference to a figure with no context. Therefore, the description cannot be generated as it lacks information to create a meaningful interpretation.*

Levalbuterol Inhalation Solution, USP is a medication that comes in a 3mL unit-dose vial containing 0.31 mg/ 3mL of levalbuterol hydrochloride salt in an aqueous solution. The solution is packaged in cartons with 25 Sterile Unit-Dose Vials, which are organized into five separate pouches, each containing five unit-dose vials. The medication should only be taken as directed by a physician and should not exceed the recommended dosage. The solution does not contain any preservatives and should be stored in a cool and dry place, away from excessive light and heat. Unit-dose vials should remain stored in the protective foil pouch at all times, and once removed from the foil pouch, the individual vials must be used within one week. It is essential to discard the solution if it is not colorless. Patients are advised to detach the "patients' instruction for Use" document from the package and keep it with the product.*

The text is a product description for Levalbuterol Inhalation Solution, USP. It contains information about the contents of each 3mL vial, dosage, storage instructions, and safety precautions. It should be used only as directed by a physician and is for oral inhalation only. The product does not contain preservatives and comes in a carton with 25 sterile unit-dose vials. The vials should be stored in a protective foil pouch and discarded if the solution is not colorless. The text also provides manufacturing and distributing details.*

This is a description of a medication in inhalation solution form, manufactured by Cipla Ltd for Dr. Reddy’s Laboratories, Inc. The medication is Levalbuterol Inhalation Solution in a strength of 1.25 mg/3 mL, contained in a sterile unit-dose vial. Each vial contains Levalbuterol hydrochloride in an aqueous solution with no preservatives. The solution contains edetatedisodium, sodium chloride, and sulfuric acid to adjust its pH to 4.0. The medication has storage requirements and usage instructions for the pharmacist and the patient. The carton contains 25 vials of 3 mL each in 5 pouches of 5 vials each. However, some parts of the text are blurry, distorted, or missing due to the quality of the result.*